Showing results (361-370 of 379) with videos related to
Sort By:
Pageof 38
The European Respiratory Journal|June 12, 2025
Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): Results of a multi-centre randomised controlled trialBarry J Plant, Gisli G Einarsson, Kevin F Deasy, et al.International Journal of Environmental Research and Public Health|April 3, 2021
SARS-CoV-2 Infection, Risk Perception, Behaviour and Preventive Measures at Schools in Berlin, Germany, during the Early Post-Lockdown Phase: A Cross-Sectional StudyFranziska Hommes, Welmoed van Loon, Marlene Thielecke, et al.Cell Stem Cell|February 22, 2020
CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid BiobankMaarten H Geurts, Eyleen de Poel, Gimano D Amatngalim, et al.Cell Reports. Medicine|August 20, 2025
Rewired type I IFN signaling is linked to age-dependent differences in COVID-19Lev Petrov, Sophia Brumhard, Sebastian Wisniewski, et al.The Lancet. Respiratory Medicine|September 12, 2023
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspectiveNicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 22, 2022
Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway diseaseCamilla Margaroli, Hamed Horati, Luke W Garratt, et al.Nature|July 30, 2020
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19Julian Braun, Lucie Loyal, Marco Frentsch, et al.Frontiers in Molecular Biosciences|July 10, 2026
Pulmonary exacerbations in patients with genetically confirmed PCD: a prospective observational multicentre studyPinelopi Anagnostopoulou, Panayiotis Kouis, Dilber Ademhan Tural, et al.Science Translational Medicine|January 22, 2025
Perinatal dysfunction of innate immunity in cystic fibrosisFlorian Jaudas, Florian Bartenschlager, Bachuki Shashikadze, et al.Science (New York, N.Y.)|September 1, 2021
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccinationLucie Loyal, Julian Braun, Larissa Henze, et al.Pageof 38